(Q45203862)

English

Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.

scientific article published on 21 November 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Hepatitis B virus

1 reference

based on heuristic

inferred from title

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Yi-Hsuan Hsieh

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Ih-Jen Su

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Chia-Jui Yen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Ting-Fen Tsai

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Hung-Wen Tsai

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Han-Ni Tsai

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Yu-Jun Huang

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Yen-Yu Chen

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Yu-Lin Ai

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Lin-Yuan Kao

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Wen-Chuan Hsieh

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Wenya Huang

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

language of work or name

0 references

publication date

21 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

475-485

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23172669%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

The hepatitis B virus X protein activates nuclear factor of activated T cells (NF-AT) by a cyclosporin A-sensitive pathway

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Viral hepatocarcinogenesis: from infection to cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Identification of a pre-S2 mutant in hepatocytes expressing a novel marginal pattern of surface antigen in advanced diseases of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

A clustered ground-glass hepatocyte pattern represents a new prognostic marker for the recurrence of hepatocellular carcinoma after surgery.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Hepatocellular carcinoma: cost-effectiveness of screening. A systematic review

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

A pre-S gene chip to detect pre-S deletions in hepatitis B virus large surface antigen as a predictive marker for hepatoma risk in chronic hepatitis B virus carriers.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Clinical development of histone deacetylase inhibitors as anticancer agents

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Chemopreventive effect of silymarin on liver pathology in HBV X protein transgenic mice

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Cell cycle and apoptotic effects of SAHA are regulated by the cellular microenvironment in HCT116 multicellular tumour spheroids.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

3,3'-diindolylmethane enhances the efficacy of butyrate in colon cancer prevention through down-regulation of survivin

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Thioredoxin and thioredoxin binding protein 2 in the liver

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Posttranslational regulation of NF-YA modulates NF-Y transcriptional activity.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS365

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45203862&oldid=1287821916"